[1]
|
Pichler BJ, Wehrl HF, Judenhofer MS. Latest advances in molecular imaging instrumentation. J Nucl Med, 2008, 49(Suppl 2): 5S-23S. doi: 10.2967/jnumed.108.045880 |
[2]
|
Antoch G, Bockisch A. Combined PET/MRI: a new dimension in whole-body oncology imaging?. Eur J Nucl Med Mol Imaging, 2009, 36(Suppl 1): S113-S120. |
[3]
|
Bolus NE, George R, Washington J, et al. PET/MRI: the blendedmodality choice of the future?. J Nucl Med Technol, 2009, 37(2): 63-71. doi: 10.2967/jnmt.108.060848 |
[4]
|
Wehrl HF, Judenhofer MS, Wiehr S, et al. Pre-clinical PET/MR: technological advances and new perspectives in biomedical research. EurJ Nucl Med Mol Imaging, 2009, 36(Suppl1): S56-S68. |
[5]
|
Delso G, Ziegler S. PET/MRI system design. Eur J Nucl Med MolImaging, 2009, 36(Suppl 1): S86-S92. |
[6]
|
Sauter AW, Wehrl HF, Kolb A, et al. Combined PET/MRI: one stepfurther in multimodality imaging. Trends Mol Med, 2010, 16(11): 508-515. doi: 10.1016/j.molmed.2010.08.003 |
[7]
|
Shao Y, Cherry S R, Farahani K, et al. Development of a PET detector system compatible with MRI/NMR systems. IEEE Trans Nucl Sci, 1997, 44(3): 1167-1171. doi: 10.1109/23.596982 |
[8]
|
Marsden PK, Strul D, Keevil SF, et al. Simultaneous PET and NMR. Br J Radiol, 2002, 75(Suppl 9): S53-S59. |
[9]
|
Pichler BJ, Swann BK, Rochelle J, et al. Lutetium oxyorthosilicate block detector readout by avalanche photodiode arrays for high resolution animal PET. Phys Med Biol, 2004, 49(18): 4305-4319. doi: 10.1088/0031-9155/49/18/008 |
[10]
|
M artinez-Möller A, Souvatzoglou M, Delso G, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med, 2009, 50(4): 520-526. doi: 10.2967/jnumed.108.054726 |
[11]
|
Judenhofer MS, Wehrl HF, Newport DF, et al. Simultaneous PETMRI: a new approach for functional and morphological imaging. Nat Med, 2008, 14(4): 459-465. doi: 10.1038/nm1700 |
[12]
|
Catana C, Procissi D, Wu Y, et al. Simultaneous in vivo positron emission tomography and magnetic resonance imaging. Proc Natl Acad Sci U S A, 2008, 105(10): 3705-3710. doi: 10.1073/pnas.0711622105 |
[13]
|
Schlemmer HP, Pichler BJ, Krieg R, et al. An integrated MR/PET system: prospective applications. Abdom Imaging, 2009, 34(6): 668-674. doi: 10.1007/s00261-008-9450-2 |
[14]
|
Schlemmer HP, Pichler BJ, Schmand M, et al. Simultaneous MR/ PET imaging of the human brain: feasibility study. Radiology, 2008, 248(3): 1028-1035. doi: 10.1148/radiol.2483071927 |
[15]
|
Schlemmer HP, Pichler B, Wienhard K, et al. Simultaneous MR/ PET for brain imaging: first patient scans. J Nucl Med, 2007, 48(Suppl 2): 45P. |
[16]
|
Boss A, Kolb A, Hofmann M, et al. Diffusion tensor imaging in a human PET/MR hybrid system. Invest Radiol, 2010, 45(5): 270-274. doi: 10.1097/RLI.0b013e3181dc3671 |
[17]
|
Lucas AJ, Hawkes RC, Ansorge RE, et al. Development of a combined microPET-MR system. Technol Cancer Res Treat, 2006, 5(4): 337-341. doi: 10.1177/153303460600500405 |
[18]
|
Yamamoto S, Imaizumi M, Kanai Y, et al. Design and performance from an integrated PET/MRI system for small animals. Ann Nucl Med, 2010, 24(2): 89-98. doi: 10.1007/s12149-009-0333-6 |
[19]
|
Handler W, Chronik B, Scholl T, et al. Combining field-cycled magnetic resonance imaging with positron emission tomography. J Nucl Med, 2007, 48(Suppl 2): 89p. |
[20]
|
Gilbert KM, Handler WB, Scholl TJ, et al. Design of field-cycled magnetic resonance systems for small animal imaging. Phys Med Biol, 2006, 51(11): 2825-2841. doi: 10.1088/0031-9155/51/11/010 |
[21]
|
Hofmann M, Steinke F, Scheel V, et al. MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration. J Nucl Med, 2008, 49(11): 1875-1883. doi: 10.2967/jnumed.107.049353 |
[22]
|
Keereman V, Fierens Y, Broux T, et al. MRI-based attenuation correction for PET/MRI using ultrashort echo time sequences. J Nucl Med, 2010, 51(5): 812-818. doi: 10.2967/jnumed.109.065425 |
[23]
|
Schulz V, Torres-Espallardo I, Renisch S, et al. Automatic, threesegment, MR-based attenuation correction for whole-body PET/MR data. Eur J Nucl Med Mol Imaging, 2011, 38(1): 138-152. doi: 10.1007/s00259-010-1603-1 |
[24]
|
Salomon A, Goedicke A, Schweizer B, et al. Simultaneous reconstruction of activity and attenuation for PET/MR. IEEE Trans Med Imaging, 2011, 30(3): 804-813. doi: 10.1109/TMI.2010.2095464 |
[25]
|
Hofmann M, Pichler B, Schölkopf B, et al. Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques. Eur J Nucl Med Mol Imaging, 2009, 36(Suppl 1): S93-S104. |
[26]
|
Thesen S, Heid O, Mueller E, et al. Prospective acquisition correction for head motion with image-based tracking for real-time fMRI. Magn Reson Med, 2000, 44(3): 457-465. doi: 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R |
[27]
|
Catana C, Benner T, van der Kouwe A, et al. MRI-assisted PET motion correction for neurologic studies in an integrated MR-PET scanner. J Nucl Med, 2011, 52(1): 154-161. doi: 10.2967/jnumed.110.079343 |
[28]
|
Cho ZH, Son YD, Kim HK, et al. A fusion PET-MRI system with a high-resolution research tomograph-PET and ultra-high field 7.0 T-MRI for the molecular-genetic imaging of the brain. Proteomics, 2008, 8(6): 1302-1323. doi: 10.1002/pmic.200700744 |
[29]
|
Cho ZH, Son YD, Kim HK, et al. Substructural hippocampal glucose metabolism observed on PET/MRI. J Nucl Med, 2010, 51(10): 1545-1548. doi: 10.2967/jnumed.110.076182 |
[30]
|
Cho ZH, Son YD, Kim HK, et al. Horizontal versus longitudinal axis of the hippocampus: metabolic differentiation as measured with high-resolution PET/MRI. J Nucl Med, 2011, [Epub ahead of print]. |
[31]
|
Cho ZH, Son YD, Kim HK, et al. Observation of glucose metabolism in the thalamic nuclei by fusion PET/MRI. J Nucl Med, 2011, 52(3): 401-404. doi: 10.2967/jnumed.110.081281 |
[32]
|
Thor warth D, Henke G, Müller AC, et al. Simultaneous(68)Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience. Int J Radiat Oncol Biol Phys, 2011, 81(1): 277-283. doi: 10.1016/j.ijrobp.2010.10.078 |
[33]
|
Chapon C, Jackson JS, Aboagye EO, et al. An in vivo multimodal imaging study using MRI and PET of stem cell transplantation after myocardial infarction in rats. Mol Imaging Biol, 2009, 11(1): 31-38. doi: 10.1007/s11307-008-0174-z |
[34]
|
Ciccarelli O, Catani M, Johansen-Berg H, et al. Diffusion-based tractography in neurological disorders: concepts, applications, and future developments. Lancet Neurol, 2008, 7(8): 715-727. doi: 10.1016/S1474-4422(08)70163-7 |
[35]
|
Büscher K, Judenhofer MS, Kuhlmann MT, et al. Isochronous assessment of cardiac metabolism and function in mice using hybrid PET/MRI. J Nucl Med, 2010, 51(8): 1277-1284. doi: 10.2967/jnumed.110.076448 |
[36]
|
Nekolla SG, Martinez-Moeller A, Saraste A. PET and MRI in cardiac imaging: from validation studies to integrated applications. Eur J Nucl Med Mol Imaging, 2009, 36(Suppl 1): S121-S130. |
[37]
|
Daftary A. PET-MRI: challenges and new directions. Indian J Nucl Med, 2010, 25(1): 3-5. doi: 10.4103/0972-3919.63590 |
[38]
|
Van Goethem M, Tjalma W, Schelfout K, et al. Magnetic resonance imaging in breast cancer. Eur J Surg Oncol, 2006, 32(9): 901-910. doi: 10.1016/j.ejso.2006.06.009 |
[39]
|
Bao A, Goins B, Dodd GD 3rd, et al. Real-time iterative monitoring of radiofrequency ablation tumor therapy with 15O-water PETimaging. J Nucl Med, 2008, 49(10): 1723-1729. doi: 10.2967/jnumed.108.052886 |
[40]
|
Lee S, Chen X. Dual-modality probes for in vivo molecular imaging. Mol Imaging, 2009, 8(2): 87-100. |
[41]
|
Lee HY, Li Z, Chen K, et al. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic(RGD)-conjugated radiolabeled iron oxide nanoparticles. J Nucl Med, 2008, 49(8): 1371-1379. doi: 10.2967/jnumed.108.051243 |
[42]
|
Xie J, Huang J, Li X, et al. Iron oxide nanoparticle platform for biomedic alapplications. Curr Med Chem, 2009, 16(10): 1278-1294. doi: 10.2174/092986709787846604 |
[43]
|
Cheon J, Lee JH. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc Chem Res, 2008, 41(12): 1630-1640. doi: 10.1021/ar800045c |
[44]
|
Shokeen M, Fettig NM, Rossin R. Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles. Q J Nucl Med Mol Imaging, 2008, 52(3): 267-277. |
[45]
|
Glaus C, Rossin R, Welch MJ, et al. In vivo evaluation of (64)Culabeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. Bioconjug Chem, 2010, 21(4): 715-722. doi: 10.1021/bc900511j |
[46]
|
Patel D, Kell A, Simard B, et al. The cell labeling efficacy, cytotoxicity and relaxivity of copper-activated MRI/PET imaging contrast agents. Biomaterials, 2011, 32(4): 1167-1176. doi: 10.1016/j.biomaterials.2010.10.013 |
[47]
|
Xie J, Chen K, Huang J, et al. PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials, 2010, 31(11): 3016-3022. doi: 10.1016/j.biomaterials.2010.01.010 |
[48]
|
Park JC, Yu MK, An GI, et al. Facile preparation of a hybrid nanoprobe for triple-modality optical/PET/MR imaging. Small, 2010, 6(24): 2863-2868. doi: 10.1002/smll.201001418 |
[49]
|
Stelter L, Pinkernelle JG, Michel R, et al. Modification of aminosilanized superparamagnetic nanoparticles: feasibility of multimodal detection using 3T MRI, small animal PET, and fluorescence imaging. Mol Imaging Biol, 2010, 12(1): 25-34. doi: 10.1007/s11307-009-0237-9 |
[50]
|
Higuchi T, Anton M, Dumler K, et al. Combined reporter gene PET and iron oxide MRI for monitoring survival and localization of transplanted cells in the rat heart. J NuclMed, 2009, 50(7): 1088-1094. |
[51]
|
Uppal R, Catana C, Ay I, et al. Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe--feasibility study in rat model. Radiology, 2011, 258(3): 812-820. doi: 10.1148/radiol.10100881 |